Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
US9102670B2 · kind B2 · utility
2Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2013 |
| Grant date | Aug 11, 2015 |
| Priority date | — |
| Expiry date | Apr 9, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D475/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a compound of formula I:or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.